GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Encompass Health Corp (NYSE:EHC) » Definitions » Cash Flow from Financing

Encompass Health (Encompass Health) Cash Flow from Financing : $-197 Mil (TTM As of Dec. 2023)


View and export this data going back to 1989. Start your Free Trial

What is Encompass Health Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Dec. 2023, Encompass Health paid $0 Mil more to buy back shares than it received from issuing new shares. It spent $6 Mil paying down its debt. It paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $15 Mil paying cash dividends to shareholders. It spent $9 Mil on other financial activities. In all, Encompass Health spent $30 Mil on financial activities for the three months ended in Dec. 2023.


Encompass Health Cash Flow from Financing Historical Data

The historical data trend for Encompass Health's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Encompass Health Cash Flow from Financing Chart

Encompass Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.20 -145.90 -240.10 -145.70 -197.20

Encompass Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.50 -58.00 -43.50 -65.80 -29.90

Encompass Health Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Encompass Health's Cash from Financing for the fiscal year that ended in Dec. 2023 is calculated as:

Encompass Health's Cash from Financing for the quarter that ended in Dec. 2023 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-197 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Encompass Health  (NYSE:EHC) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Encompass Health's issuance of stock for the three months ended in Dec. 2023 was $0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Encompass Health's repurchase of stock for the three months ended in Dec. 2023 was $0 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Encompass Health's net issuance of debt for the three months ended in Dec. 2023 was $-6 Mil. Encompass Health spent $6 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Encompass Health's net issuance of preferred for the three months ended in Dec. 2023 was $0 Mil. Encompass Health paid $0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Encompass Health's cash flow for dividends for the three months ended in Dec. 2023 was $-15 Mil. Encompass Health spent $15 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Encompass Health's other financing for the three months ended in Dec. 2023 was $-9 Mil. Encompass Health spent $9 Mil on other financial activities.


Encompass Health Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Encompass Health's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Encompass Health (Encompass Health) Business Description

Traded in Other Exchanges
Address
9001 Liberty Parkway, Birmingham, AL, USA, 35242
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
Executives
Douglas E Coltharp officer: EVP, Chief Financial Officer C/O UNDER ARMOUR, INC., 1020 HULL STREET, BALTIMORE MD 21230
Elissa Joy Charbonneau officer: Chief Medical Officer 24 HAWTHORNE CIRCLE, YARMOUTH ME 04096
Mark J Tarr officer: Executive VP Operations C/O ENCOMPASS HEALTH CORPORATION, 9001 LIBERTY PARKWAY, BIRMINGHAM AL 35242
Greg D Carmichael director
Kevin J. O'connor director 13995 PASTEUR BOULEVARD, PALM BEACH GARDENS FL 33418
Terrance Williams director 7184 BIDDICK, NEW ALBANY OH 43054
Christopher R Reidy director ONE ADP BLVD, ROSELAND NJ 07068
Andrew L Price officer: Interim Chief Accting Officer 3660 GRANDVIEW PARKWAY, SUITE 200, BIRMINGHAM AL 35243
Barbara Ann Jacobsmeyer officer: EVP, Operations 2122 ACTON PARK WAY, BIRMINGHAM AL 35243
Donald L Correll director C/O INTERCHANGE FINANCIAL SERVICES CORP, PARK 80 W PLAZA TWO, SADDLE BROOK NJ 07663
Anthony April Kaye Bullock officer: CEO and President, Encompass 3606 PRINCETON AVENUE, DALLAS TX 75205
Higdon Leo I Jr director 1700 LINCOLN STREET, 28TH FLOOR, DENVER CO 80203
Patricia Anne Maryland director 7342 HORIZON DRIVE, WEST PALM BEACH FL 33412
Yvonne M Curl director C/O ENHABIT, INC., 6688 N. CENTRAL EXPRESSWAY, SUITE 1300, DALLAS TX 75206
Cheryl B. Levy officer: Chief Human Resources Officer 3137 BROOK HIGHLAND DRIVE, BIRMINGHAM AL 35242